BiotechTube

CSL511 Fibrinogen concentrate (human) + Cryoprecipitate

Phase 3Recruiting
0 watching 0 views this week📈 Rising
76
Hype Score

Development Stage

✓
Pre-clinical
✓
Phase 1
✓
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Acquired Fibrinogen Deficiency

Conditions

Acquired Fibrinogen Deficiency

Trial Timeline

Oct 1, 2024 → Oct 29, 2027

NCT ID
NCT06617897

About CSL511 Fibrinogen concentrate (human) + Cryoprecipitate

CSL511 Fibrinogen concentrate (human) + Cryoprecipitate is a phase 3 stage product being developed by CSL for Acquired Fibrinogen Deficiency. The current trial status is recruiting. This product is registered under clinical trial identifier NCT06617897. Target conditions include Acquired Fibrinogen Deficiency.

Hype Score Breakdown

Clinical
27
Activity
18
Company
9
Novelty
9
Community
10

Clinical Trials (1)

NCT IDPhaseStatus
NCT06617897Phase 3Recruiting

Competing Products

20 competing products in Acquired Fibrinogen Deficiency

See all competitors
ProductCompanyStageHype Score
ONO-5046Na + ONO-5046NaOno PharmaceuticalPhase 2
52
epoetin alfaJohnson & JohnsonPhase 2
52
epoetin alfaJohnson & JohnsonPhase 2
52
HRS-8427 + MeropenemJiangsu Hengrui MedicinePhase 2
52
Ticagrelor + PlaceboAstraZenecaPhase 2
52
IMI/REL FDC + PIP/TAZ FDC + LinezolidMerckPhase 3
77
Raltegravir + AtazanavirMerckPre-clinical
23
Emicizumab InjectionRochePhase 2
52
PI + RTV + FTC/TDF + StribildGilead SciencesPhase 3
76
E/C/F/TDF + COBI + ATV + DRV + NRTIGilead SciencesPhase 3
76
COBI + DRV + NRTIsGilead SciencesPhase 3
76
StribildGilead SciencesPhase 3
76
ATV + DRV + Cobicistat + BR + F/TAF + LPV/r + Third Unboosted Drug + Cobicistat TOS + F/TAF TOSGilead SciencesPhase 2/3
64
D/C/F/TAF + DRV + COBI + FTC/TDF + D/C/F/TAF Placebo + DRV Placebo + COBI Placebo + FTC/TDF PlaceboGilead SciencesPhase 2
51
Lopinavir 400 mg/ritonavir 100 mg + EfavirenzGilead SciencesApproved
84
E/C/F/TAF + E/C/F/TAF (Low Dose)Gilead SciencesPhase 2/3
64
E/C/F/TDF + ATV + RTV + FTC/TDF + E/C/F/TDF Placebo + ATV Placebo + RTV Placebo + FTC/TDF Placebo + E/C/F/TAFGilead SciencesPhase 3
76
NNRTI + FTC/TDF + StribildGilead SciencesPhase 3
76
E/C/F/TDF + E/C/F/TAF Placebo + E/C/F/TAF + E/C/F/TDF PlaceboGilead SciencesPhase 2
51
EVG + Background regimenGilead SciencesPhase 2/3
64

Other Products from CSL

IgPro10Approved
84
four factor prothrombin complex concentrateApproved
84
Prothrombin complex concentrate (Human) + Fresh frozen plasma (FFP)Approved
84
IgPro10Approved
84
Blood coagulation Factor VIII and vWF, humanApproved
84